Who’s Betting On Gilead Sciences, Inc. (GILD)?
If you were to ask many investors, hedge funds are seen as delayed, old financial vehicles of an era lost to time.
Posts Tagged ‘NASDAQ:BIIB’
Biogen Idec Inc. (BIIB), Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Novartis AG (ADR) (NVS): Companies Leading the Fight Against Multiple Sclerosis
It's a disease that doesn't often find itself in the spotlight, but multiple sclerosis is quickly becoming an ailment that drugmakers are focusing their efforts on to make a quality...
Baxter International Inc. (BAX), Halozyme Therapeutics, Inc. (HALO): This Healthcare Company Is Poised for Growth
The performance of Baxter International Inc. (NYSE:BAX), the world’s second-largest maker of dialysis products, has been lagging the market with 7.38% gain YTD as of Aug 2, ...
Sanofi SA (ADR) (SNY), GlaxoSmithKline plc (ADR) (GSK): This Company Is Tackling Multiple Sclerosis Head On
Currently existing immunomodulatory drugs that treat Multiple Sclerosis only work to treat relapse or attacks, manage symptoms, or modify the course of the disease.
Elan Corporation, plc (ADR) (ELN), Perrigo Company (PRGO): Examining an Acquisition That Benefits This Global Healthcare Supplier
Recently, Elan Corporation, plc (ADR) (NYSE:ELN) ended the fight against bids from Royalty Pharma.
Biogen Idec Inc (BIIB), Pfizer Inc. (PFE): Out With the Old, In With the New in Treating MS
Hidden beneath all the numbers and metrics in Biogen Idec Inc (NASDAQ:BIIB)'s recent earnings report is a key confirmation of a shifting market in the treatment of multiple sclerosis...
Pharmacyclics, Inc. (PCYC) Set to Glide Higher
Pharmacyclics, Inc. (NASDAQ:PCYC) has been a good company to invest in, especially if you had bought shares back in 2009 when it traded around $1 per share.
Things You Need to Know From Questcor Pharmaceuticals Inc (QCOR)’s Killer Q2 Earnings
Three months ago after Questcor Pharmaceuticals Inc (NASDAQ:QCOR) announced its first-quarter financial results, I asked if those results were as bad as they looked.
Elan Corporation, plc (ADR) (ELN), Perrigo Company (PRGO): Strange Biotech Bedfellows
When I interviewed Alkermes Plc (NASDAQ:ALKS)' CEO Richard Pops last year, he described the relocation of the company's headquarters to Ireland where taxes are lower after buying...
Monster Beverage Corp (MNST), Biogen Idec Inc (BIIB): Today’s Worst Stocks
Investors weren't blown away with today's data, which is understandable since there wasn't anything too meaningful released.
Alexion Pharmaceuticals, Inc. (ALXN), Celgene Corporation (CELG): Biotech Favorites With Noteworthy Drug Data
Three of the biggest names in biotechnology have reported earnings, and their quarters involved very important drug-related information for investors.
Questcor Pharmaceuticals Inc (QCOR), Biogen Idec Inc (BIIB): A Biotech Betting Everything on a Single Drug
Despite some negative news, mainly related to reimbursement issues and excess stock booking, Questcor Pharmaceuticals Inc (NASDAQ:QCOR) recently gained solid momentum due to a...
Amgen, Inc. (AMGN), Celgene Corporation (CELG): Is Big Biotech Still Growing?
The first half of 2013 has seen remarkable growth in the biotech sector, with the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) up >40% YTD. The industry continues to...
Baxter International Inc. (BAX), Medtronic, Inc. (MDT): Should You Buy These 2 Medical Device Stocks?
Medical device stocks are an excellent place to be if you are still wary of the macro-economy.
What Does Celgene Corporation (CELG)’s Failed Trial Mean for Investors?
Early this morning, Celgene Corporation (NASDAQ:CELG) announced that it was discontinuing the phase 3 ORIGIN Trial evaluating Revlimid (lenalidomide) in B-Cell chronic lymphomatic...
Biogen Idec Inc. (BIIB), Celgene Corporation (CELG), Gilead Sciences, Inc. (GILD): 3 of Biotech’s Best
It’s been a healthy year-to-date for the biotech sector, with the space logging huge gains above and beyond those of the broad based market.
Amgen, Inc. (AMGN), Celgene Corporation (CELG), Biogen Idec Inc. (BIIB): Watch Out for These 3 Biotech Companies
This year, the North American players in the biotechnology industry are expected to spend $15 billion.
Is Zoetis Inc (ZTS) Worth the Premium?
After all of the hype and hoopla over Pfizer Inc.
What’s Next for Elan Corporation, plc (ADR) (ELN)?
Elan Corporation, plc (ADR) (NYSE:ELN)'s board unanimously rebuffed a $6.7 billion takeover offer from Royalty Pharma in early June and hired Citigroup Inc.
Valeant Pharmaceuticals Intl Inc (VRX), Hospira, Inc. (HSP), Elan Corporation, plc (ADR) (ELN): 3 Pharma Companies to Buy for the Long Run
According to IMS health report, the global pharmaceutical industry is expected to grow at a CAGR of 4.5% in the next five years to reach $1.20 trillion in 2017, from $963 billion...
VIVUS, Inc. (VVUS): An Obese Proxy Fight
Proxy fights are like the demolition derby of the investment world.
Alexion Pharmaceuticals, Inc. (ALXN), Harman International Industries Inc./DE/ (HAR): Today’s 3 Best Stocks
Under normal circumstances, the markets would sell off on news that the U.S. Commerce Department made a downward revision to its final first-quarter GDP growth figure.
Amgen, Inc. (AMGN): The Only True Biotech Dividend Stock
Dividend stocks are hard to come by in the biotech space.
Biogen Idec Inc (BIIB), BlackRock, Inc. (BLK): Picks and Pans for the Pullback
The U.S. stock market is down around 6%, Treasuries are getting crushed, bond funds are down, and gold is down.
Time to Buy Amgen, Inc. (AMGN)?
A double-digit drop for Amgen, Inc. (NASDAQ:AMGN) stock over the past couple of months has likely left a bad taste in the mouths of shareholders.
Biogen Idec Inc. (BIIB), Alexion Pharmaceuticals, Inc. (ALXN): Best-Run Biotech Companies
Which biotech companies are the best-run? That could be a difficult question to answer, since there are many perspectives on what constitutes a well-run company.
Is Elan Corporation, plc (ADR) (ELN) Pushing Its Luck?
Recently Elan Corporation, plc (ADR) (NYSE:ELN)'s shareholders voted against management's proposal to invest $1 billion in Theravance Inc (NASDAQ:THRX), a deal which a fellow...
Biogen Idec Inc. (BIIB): Elan Corporation, plc (ADR) (ELN) Likely To Receive Higher Takeout Bids
Elan Corporation, plc (ADR) (NYSE:ELN) has been in the news over the past few months because of a hotly contested battle with Royalty Pharma. The battle began on Feb.
Gilead Sciences, Inc. (GILD), American International Group, Inc. (AIG): The Biggest Companies That Don’t Pay Dividends — But May Be About To
The S&P 500 fell nearly 10% in June 2008, and investors began to brace for an eventual market crash later in the year.
Biogen Idec Inc. (BIIB), Sanofi SA (ADR) (SNY): A Must Have Pharma Stock
After a year-long dream run, Biogen Idec Inc. (NASDAQ:BIIB) lost 5.25% in the week ended Friday, June 7.
Biotechs Lose Ground As Achillion Pharmaceuticals, Inc. (ACHN) Takes a Dive
Biotechnology's a volatile sector that can intimidate many investors, but it's also a landscape of stocks that can reward portfolios with giant gains.
First Solar, Inc. (FSLR), Biogen Idec Inc. (BIIB), Electronic Arts Inc. (EA): Today’s Three Worst Stocks
It's been a tough week for equities.
Biogen Idec Inc. (BIIB): Will This Company Dominate the Multiple Sclerosis Market?
With one product already on the market, one recently approved and four more in various stages of clinical development, Biogen Idec Inc.
Biogen Idec Inc. (BIIB): The Short Data You Need To See
To the untrained eye, there are many facts and figures for Biogen Idec Inc. (NASDAQ:BIIB) investors to track, but it's useful to be aware of a company's short sellers.
Biogen Idec Inc. (BIIB), salesforce.com, inc. (CRM): Today’s 3 Worst Stocks
If you somehow glossed over the title of this article, then skipped this paragraph and simply read about the following three stocks without any context, you might think that today...
Omthera Pharmaceuticals Inc (OMTH), GlaxoSmithKline plc (ADR) (GSK): This Week in Biotech
With the SPDR S&P Biotech Index up 38% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): Where to Invest for More Health-Care Exposure
You have plenty of choices of where to invest your portfolio.
Is Biogen Idec Inc. (BIIB) Going to Burn These Hedge Funds?
To most traders, hedge funds are assumed to be worthless, outdated financial tools of years past.
Do Hedge Funds and Insiders Love Celgene Corporation (CELG)?
Celgene Corporation (NASDAQ:CELG) was in 44 hedge funds' portfolio at the end of the first quarter of 2013.
Amgen, Inc. (AMGN) Stock Checkup for May
I have jokingly referred to Amgen, Inc. (NASDAQ:AMGN) in the past as a "senior citizen" of biotech. The company was founded 33 years ago, making Amgen, Inc.
Hedge Funds Are Betting On Gilead Sciences, Inc. (GILD)
To the average investor, there are a multitude of indicators market participants can use to watch stocks.
PDL BioPharma Inc. (PDLI), AbbVie Inc (ABBV): Two Scariest Dividend Stocks in Health Care
Combining nice dividends with a growing industry that comprises roughly one-fifth of the nation's GDP should make for an attractive stock -- in theory.
Visa Inc (V), Alliance Data Systems Corporation (ADS) & More: Navellier & Associates’ Top Portfolio Holdings
With roughly $2.5bn in assets under management, Navellier & Associates is a team of about twelve investment professionals that use quantitative and fundamental analysis to employ...
Celgene Corporation (CELG), Biogen Idec Inc. (BIIB), Gilead Sciences, Inc. (GILD): Don’t Try to Pick the Best Biotech Company
Rising biotech stars Celgene Corporation (NASDAQ:CELG), Biogen Idec Inc. (NASDAQ:BIIB), and Gilead Sciences, Inc.
Biogen Idec Inc. (BIIB) Bounces Higher
If you thought that the great run so far in 2013 was over for Biogen Idec Inc. (NASDAQ:BIIB), think again.
Johnson & Johnson (JNJ): Buying Isn’t for Growth Investors
If there's one health-care stock every investor knows by name, it's Johnson & Johnson (NYSE:JNJ).
Gilead Sciences, Inc. (GILD) or Biogen Idec Inc. (BIIB)? This Is What the Perfect Biotech Would Look Like
I don't know about you, but I'm pretty stoked for the NFL draft this Thursday.
